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ABSTRACT
Detection of Hepatitis C Virus Co-Infection in Hepatitis B Virus Positive Patient
Hepatitis C virus co-infection can become troublesome to any patient infected especially
when the patient had already being diagnosed with hepatitis B virus infection. It was
estimated that 130 million people globally has been infected with hepatitis C virus (HCY)
and mostly of the patient serve as reservoir for transmission to healthy people. While in
ASEAN region, there was no significant study was done for the HCY infection among
the population. The study is done to identify HCY co-infection in positive Hepatitis B
virus (HBY) patient among the Malaysian population. In this study, the total number of
HBY patient that is positive with HCY co-infection is 14 out of37 that account 37.84 %
from the total sample. Whereas, another about 62.16 % (23 people) not developing HCY
co-infection phenomena in patient with positive HBY infection. From other point of
view, the distribution of hepatitis C virus detection between gender of the patient that is
9 female patient (24.3%) and 5 male patient (13.5%).Based on the race demographic
data, it revealed that Chinese have the highest number of HCY positive detection that is
6 people (6.2 %), followed by Malay with 5 people (13.5%), Other races with 2 people
(5.4%) and lastly Indian race with 1 person (2.7%). Based on the data between the
number of HCY detection among the different diagnosis of HBY positive patient, 7
people (18.9%) with hepatitis disease positive with HCY detection by using real time
PCR, followed by 5 (13.5%) people with chronic hepatitis disease, 2 (5.4%) people with
cirrhosis disease and none from the people with hepatocellular carcinoma infect with
HCY. The use of real time PCR assay had demonstrated a highly sensitive and specific
method to detect HCY in patient sample with positive HBY virus. As for the conclusion,
the result produce clearly show that the HCY can became a co-infection to the patient
that had already being infect with HBY.
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CHAPTER I 
INTRODUCTION 
[.1 Background of Study 
Hepatiﬁs C is a liver disease that is caused by hepatitis C virus (HCV) which can 
cause both acute and chronic hepatitis infection. It is was estimated that 130 million 
people globally has been infected with hepatitis C virus and mostly of the patient 
serve as reservoir for transmission to healthy people (Alter, 2007), Apart from 
hepatitis A and hepatitis B, the HCV is the most important causal causative agent 
and has emerged as a major public health problem (Pembrey. L4, ML, Newell, 1999). 
Since because of insufﬁcient data on ‘he prevalence of HCV in many country, the 
estimation of HCV incidence is based on the weighted averages for region rather 
than individual country data (Alter, 2007). 
The highest prevalence of HCV in the world occur in Egypt, which the prevalence of 
infection rise steadily with age, between 12% and 18% of the entire Egypt 
population (Zahran, Badary, Agban, & Abdel Aziz, 2010)‘ However, the highest 
prevalence according to the region is in Africa (53%), followed by Ihe East 
Mediterranean (4.6%), western Paciﬁc (3.9%), and South East Asia (2.|5%) and 
Europe is though! to have the lowest prevalence of HCV (1.03%) (Uhanova, Tate, 
Talaryn, & Minuk, 20l2)‘ In Europe, the epidemiology of HCV is progressively 
changing and the ,"‘ ' ' e ' r (' " ,. ' c, genotype 
distribution and disease transmission patterns) have evolved substantially during the 
last IS years(Esteban, Sauleda, & Quer, 2008)‘ In North America, the prevalence is 
calculated at 16% in the USA and 0.8% in Canada‘
